ID
14816
Description
A Phase 1 Study Evaluating AMG 232 in Advanced Solid Tumors or Multiple Myeloma; ODM derived from: https://clinicaltrials.gov/show/NCT01723020
Link
https://clinicaltrials.gov/show/NCT01723020
Keywords
Versions (1)
- 4/29/16 4/29/16 -
Uploaded on
April 29, 2016
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Advanced Malignancy NCT01723020
Eligibility Advanced Malignancy NCT01723020
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
brain metastases
Data type
boolean
Alias
- UMLS CUI [1]
- C0220650
Description
hematological malignancies
Data type
boolean
Alias
- UMLS CUI [1]
- C0376545
Description
active infection requiring intravenous (iv) antibiotics
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0199779
- UMLS CUI [1,2]
- C0009450
Description
cancer treatment
Data type
boolean
Alias
- UMLS CUI [1]
- C0920425
Description
radiation
Data type
boolean
Alias
- UMLS CUI [1]
- C1522449
- UMLS CUI [2]
- C3898008
Description
currently enrolled in another investigational device or drug study
Data type
boolean
Alias
- UMLS CUI [1]
- C2348568
Similar models
Eligibility Advanced Malignancy NCT01723020
- StudyEvent: Eligibility
C1271729 (UMLS CUI [2])
C0009450 (UMLS CUI [1,2])
C3898008 (UMLS CUI [2])